Pharmacovigilance: A Practical Approach - 1st Edition - ISBN: 9780323581165, 9780323581172

Pharmacovigilance: A Practical Approach

1st Edition

Editors: Thao Doan Cheryl Renz Fabio Lievano Mondira Bhattacharya Linda Scarazzini
Paperback ISBN: 9780323581165
eBook ISBN: 9780323581172
Imprint: Elsevier
Published Date: 31st July 2018
Page Count: 228

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Written by experts in the field of pharmacovigilance and patient safety, this concise resource provides a succinct, easy-to-digest overview of an increasingly critical area of medical safety. Drs. Thao Doan, Cheryl Renz, Fabio Lievano, Mondira Bhattacharya, and Linda Scarazzini provide essential information for health care professionals, clinical researchers, and regulators who need a comprehensive, up-to-date source of information on the principles and practice of pharmacovigilance.

Key Features

  • Covers the evolving regulatory landscape, as well as current and future use of digital technologies.
  • Uses case studies to ensure content is relevant to everyday practice.
  • Discusses behavioral science and patient perspectives, risk communication, and new frontiers in pharmacovigilance.
  • Consolidates today’s available information on this timely topic into one convenient resource.

Table of Contents


Section I. The Regulatory Enviroment

1. Does Regulation Drive Science or Does Science Drive Regulation?

Section II. Data and Real World Evidence

2. Role of Epidemiology in Pharmaceutical Industry

3. Real World Epidemiologic Studies and Patient Registries

Section III. Benefit-Risk in the Drug Development Life Cycle

4. Signal Management and Methods of Signal Detection

5. Causality Assessment and Examples of Adverse Drug Reactions (Drug Induced Liver Injury, Skin, Major Adverse Cardiac Events and Renal)

6. Product Safety Monitoring in Clinical Trials

7. Benefit-Risk Assessments

8. Communicating benefit risk

9. Pharmacovigilance and Medical Devices

10. Vaccine Safety Surveillance

11. Pharmacovigilance in Special Populations (Pediatrics and Elderly)

12. Pharmacovigilance in Pregnancy

Section IV. The Role of the Digital Revolution

13. Impact and Implications of Technology on Pharmacovigilance

Section V. The Next Frontier

14. The Future of Pharmacovigilance


No. of pages:
© Elsevier 2018
31st July 2018
Paperback ISBN:
eBook ISBN:

About the Editors

Thao Doan

Affiliations and Expertise

Sr. Medical Director, Medical Safety Evaluation, AbbVie Inc., Chicago. IL

Cheryl Renz

Affiliations and Expertise

Senior Medical Director, Safety Science, Pharmacovigilance and Patient Safety, AbbVie, North Chicago, Illinois, United States

Fabio Lievano

Affiliations and Expertise

Vice President, Safety Sciences, Medical Safety Evaluation Pharmacovigilance and Patient Safety AbbVie Inc., Chicago. IL

Mondira Bhattacharya

Affiliations and Expertise

Head, Benefit-Risk Management, Innovative Platforms Initiative & Epidemiology, Pharmacovigilance and Patient Safety, AbbVie Inc., Chicago. IL

Linda Scarazzini

Affiliations and Expertise

Vice President, Pharmacovigilance and Patient Safety, AbbVie Inc., Chicago. IL